This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Access Bio, Inc.. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: Suji Lee: Innovator in Diagnostic Assay Technology
Introduction
Suji Lee is a prominent inventor based in Cherry Hill, NJ (US), known for her contributions to the field of diagnostic assay technology. With a focus on developing innovative devices for detecting pathogens, she has made significant strides in improving diagnostic methods.
Latest Patents
Suji Lee holds 3 patents related to diagnostic assay devices. Her latest patents include a diagnostic assay device having a microreactor, which is designed to detect the presence of an analyte in a sample solution. This device is configured to form a sample solution containing the analyte, flow it through a microreactor to create an analyte-capture molecule complex, and transfer the solution to an absorbent strip pad. The device can identify the presence of various pathogens, including SARS-Cov2, RSV, influenza A, and influenza B. Additionally, her patent on diagnostic assay methods using the assay device further enhances the capabilities of these diagnostic tools.
Career Highlights
Suji Lee is currently associated with Access Bio, Inc., where she continues to innovate in the field of diagnostics. Her work focuses on creating devices that improve the accuracy and efficiency of pathogen detection, which is crucial for public health.
Collaborations
Throughout her career, Suji has collaborated with notable colleagues, including Young Ho Choi and Jungho Back. These collaborations have contributed to the advancement of her research and the development of her patented technologies.
Conclusion
Suji Lee's innovative work in diagnostic assay technology has positioned her as a key figure in the field. Her patents reflect her commitment to enhancing diagnostic methods, ultimately benefiting healthcare and patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
